Interleukin-1 alpha genotype and outcome of unrelated donor haematopoietic stem cell transplantation for chronic myeloid leukaemia

British Journal of Haematology

Volumn 137, Issue 2, 2007, Pages 152-157

  Mehta, Parinda A ^a,f   Eapen, Mary ^b   Klein, John P ^b   Gandham, Sharavi ^b   Elliott, James ^a   Zamzow, Tiffany ^a   Combs, Michelle ^a   Aplenc, Richard ^c   MacMillan, Margaret L ^d   Weisdorf, Daniel J ^d   Petersdorf, Effie ^e   Davies, Stella M ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e Fred Hutchinson Cancer Research Center   (United States)

^f CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Chronic myeloid leukaemia; Haematopoietic stem cell transplantation; Interleukin 1; Polymorphisms; Unrelated donor

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; INTERLEUKIN 1ALPHA; TACROLIMUS;

ADULT; ALLELE; ARTICLE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DONOR SELECTION; FEMALE; GENOTYPE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MYELOABLATIVE CONDITIONING; PRIORITY JOURNAL; RECIPIENT; T CELL DEPLETION; T LYMPHOCYTE; TREATMENT OUTCOME; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; ALLELES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; INTERLEUKIN-1ALPHA; LEUKEMIA, MYELOID, CHRONIC; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROGNOSIS; RECURRENCE; TREATMENT OUTCOME;

EID: 33947527879     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2007.06552.x     Document Type: Article

References (17)

1. Cavet, J., Middleton, P.G., Segall, M., Noreen, H., Davies, S.M. & Dickinson, A.M. (1999) Recipient tumor necrosis factor-alpha and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus host disease severity in HLA-matched sibling bone marrow transplants. Blood, 94, 3941-3946.
2. Cavet, J., Dickinson, A.M., Norden, J., Taylor, P.R., Jackson, G.H. & Middleton, P.G. (2001) Interferon-gamma and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA matched sibling bone marrow transplantation. Blood, 98, 1594-1600.
3. Cox, D.R. (1972) Regression models and life tables. Journal of the Royal Statistical Society, 34, 187.
4. Cullup, H., Dickinson, A.M., Jackson, G.H., Taylor, R.P., Cavet, J. & Middleton, P.G. (2001) Donor interleukin 1 receptor antagonist genotype associated with acute graft-versus-host disease in human leucocyte antigen matched sibling allogeneic transplants. British Journal of Haematology, 113, 807-813.
5. Cullup, H., Dickinson, A.M., Cavet, J., Jackson, G.H. & Middleton, P.G. (2003) Polymorphisms of interleukin-1alpha constitute independent risk factors for chronic graft-versus-host disease after allogeneic bone marrow transplantation. British Journal of Haematology, 122, 778-787.
6. Ferrara, J.L. & Deeg, H.J. (1991) Graft-versus-host disease. The New England Journal of Medicine, 324, 667-674.
7. Hurme, M. & Santtila, S. (1998) IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1beta genes. European Journal of Immunology, 28, 2598-2602.
8. Keen, L.J., DeFor, T.E., Bidwell, J.L., Davies, S.M., Bradley, B.A. & Hows, J.M. (2004) Interleukin-10 and tumor necrosis factor alpha region haplotypes predict transplant-related mortality after unrelated donor stem cell transplantation. Blood, 103, 3599-3602.
9. Kernan, N.A., Bartsch, G., Ash, R.C., Beatty, P.G., Champlin, R., Filipovich, A., Gajewski, J., Hansen, J.A., Hanslee-Downey, J., McCullough, J. McGlave, P., Perkins, H.A., Phillips, G.L., Sanders, J., Stroncek, D., Thomas, E.D. & Blume K.G. (1993) Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. The New England Journal of Medicine, 328, 593-602.
10. Klein, J. & Moeschberger, M. (2003) Survival Analysis: Techniques of Censored and Truncated Data. Springer-Verlag, New York, NY.
11. Lin, M.-T., Martin, P.J., Tseng, L.-H. Singleton, K., Martin, E., Petersodrf, E. & Hansen, J. (2000) Correlation between polymorphisms of the IL-1 gene complex and development of acute graft-versus-host disease after hematopoietic cell transplantation. Blood, 96, 396a.
12. Lin, M.T., Storer, B., Martin, P.J., Tseng, L.H., Gooley, T., Chen, P.J. & Hansen, J.A. (2003) Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation. The New England Journal of Medicine, 349, 2201-2210.
13. Lin, M.T., Storer, B., Martin, P.J., Tseng, L.H., Grogan, B., Chen, P.J., Zhao, L.P. & Hansen, J.A. (2005) Genetic variation in the IL-10 pathway modulates severity of acute graft-versus-host disease following hematopoietic cell transplantation: synergism between IL-10 genotype of patient and IL-10 receptor beta genotype of donor. Blood, 106, 3995-4001.
14. MacMillan, M.L., Radloff, G.A., DeFor, T.E., Weisorf, D.J. & Davies, S.M. (2003) Interleukin-1 genotype and outcome of unrelated donor bone marrow transplantation. British Journal of Haematology, 121, 597-604.
15. Middleton, P.G., Taylor, P.R., Jackson, G., Proctor, S.J. & Dickinson, A.M. (1998) Cytokine gene polymorphisms associating with severe acute graft-versus-host disease in HLA-identical sibling transplants. Blood, 92, 3943-3948.
16. Przepiorka, D., Weisdorf, D., Martin, P., Klingemann, H.G., Beatty, P., Hows, J. & Thomas, E.D. (1995) 1994 Consensus Conference on acute GVHD grading. Bone Marrow Transplantation, 15, 825-828.
17. Socie, G., Loiseau, P., Tamouza, R., Janin, A., Busson, M., Gluckman, E. & Charron, D. (2001) Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Transplantation, 72, 699-706.